Biotechnology
Biotechnology applies living systems and molecular tools across healthcare, agriculture and industry - biologics and biosimilars, cell and gene therapy, genomics and sequencing, synthetic biology, bioprocessing, and research reagents and instruments. Markets are driven by pipeline progress, funding cycles, manufacturing capacity and regulatory pathways.
Strategic Research Scope & Methodological Coverage
How Credence Research isolates pipeline attrition risk, manufacturing yield, and funding cycle exposure across biotechnology.
| Coverage Universe | Comprehensive pipeline, yield, and market sizing across: Biologics and Biosimilars, Cell and Gene Therapy, Genomics and Sequencing, Synthetic Biology, Bioprocessing Equipment, and Research Reagents and Instruments. |
| Target Decision-Makers | Chief Scientific Officers, Heads of Biomanufacturing, Venture Capital Life Sciences Partners, CDMO Corporate Development Directors, and Healthcare Private Equity investment committees requiring independent asset due diligence. |
| Primary Value Proposition | Aggregated industry estimates mask clinical development attrition and manufacturing yield failures. We measure the real economic impact of pipeline phase transition rates, bioprocessing batch failure costs, and funding cycle timing on realistic commercialization windows. |
| Geographic Corridors | United States NIH funding and FDA breakthrough designation pathways, European EMA adaptive licensing frameworks, Chinese biotech manufacturing scale-up and IND filing acceleration, and South Korean and Singaporean biomanufacturing hub investment. |
| Forecast Horizon | Dynamic 5- to 8-year capital expenditure and revenue projection models (2026 to 2034) updated continuously through clinical trial registry tracking and funding round databases. |
| Research Methodology | Direct primary engagements with biomanufacturing plant managers, venture capital life sciences partners, and clinical development executives, combined with proprietary econometric pipeline modeling rather than recycled marketing summaries. |
Sector Taxonomy & Data Assets
Systematic analysis of pipeline attrition, manufacturing yield, and funding cycle exposure across biotechnology categories.
| Vertical Sector | Primary Metric Tracked | Executive Buyer Strategic Focus | Credence Intelligence Deliverable |
|---|---|---|---|
| Biologics & Biosimilars | Titer yield per liter, phase transition success rates | Biosimilar interchangeability designation, bioreactor scale-up | Yield curve models, biosimilar launch timing forecasts |
| Cell & Gene Therapy | Vein-to-vein turnaround time, vector titer output | Allogeneic platform scalability, viral vector supply constraints | Cost-of-goods models, vector capacity mapping |
| Genomics & Sequencing | Cost per genome, sequencing throughput capacity | Clinical diagnostic adoption, population-scale sequencing programs | Cost decline curve tracking, adoption pipeline models |
| Synthetic Biology | Strain engineering cycle time, fermentation yield | Bio-based chemical substitution, precision fermentation scale-up | Fermentation economics models, commercialization readiness scores |
| Bioprocessing Equipment | Single-use system adoption rate, equipment order backlog | Modular facility design, continuous bioprocessing adoption | Equipment lead time tracking, facility capex models |
| Research Reagents & Instruments | Reagent consumption per assay, instrument utilization rates | Academic and pharma research budget allocation trends | Reagent spend forecasts, instrument placement tracking |
Industrial Intelligence & Advisory Capabilities
Proprietary research modules and transaction support for biotechnology leaders.
Biotechnology Market Snapshot
| Market | Base Size | Forecast | CAGR | Report |
|---|---|---|---|---|
| Nanotechnology Market Size, Growth, Share and Forecast 2032 | USD 6,838.11 million | USD 74,110.01 million | 34.70% | View → |
| 4D Bioprinting Market Size, Growth, Share and Forecast 2032 | USD 86.88 Million | USD 695.73 Million | 29.7% | View → |
| Cell and Gene Therapy Manufacturing Market Size and Forecast 2032 | USD 19,305.00 million | USD 146,216.60 million | 28.80% | View → |
| Black Soldier Fly Market Size, Trends, Share and Forecast 2032 | USD 339.67 million | USD 2572.67 million | 28.8% | View → |
| DNA Storage for Data Archiving Market Size, Share and Forecast 2032 | USD 1,180.44 million | USD 5,279.86 million | 28.36% | View → |
| Enzymatic DNA Synthesis Market Size, Share and Growth Report 2032 | USD 291 million | USD 1,911 million | 26.50% | View → |
| Aeroponic Biopharming Market Size, Share, Growth and Forecast 2032 | USD 1,892.38 million | USD 12,052.43 million | 26.04% | View → |
| Aptamers Market Size, Trends, Share, Growth and Forecast 2032 | USD 2.92 billion | USD 16.76 billion | 24.39% | View → |
Featured Reports
Nanotechnology Market Size, Growth, Share and Forecast 2032
4D Bioprinting Market Size, Growth, Share and Forecast 2032
Cell and Gene Therapy Manufacturing Market Size and Forecast 2032
Black Soldier Fly Market Size, Trends, Share and Forecast 2032
DNA Storage for Data Archiving Market Size, Share and Forecast 2032
Enzymatic DNA Synthesis Market Size, Share and Growth Report 2032
Aeroponic Biopharming Market Size, Share, Growth and Forecast 2032
Aptamers Market Size, Trends, Share, Growth and Forecast 2032
Biotechnology Reports
DNA and RNA Sample Preparation Market Size and Forecast 2032
DNA and RNA Sample Preparation Market size was valued at USD 2,210 million in 2024 and is anticipated to reach USD 4,265.72 million by 2032, growing at a CAGR of 8.57% during the forecast period.
North America Anti-Infectives Market Size, Growth and Forecast 2032
The North America Anti-Infectives Market size was valued at USD 26,431.85 MN in 2021 and reached USD 31,551.94 MN in 2025. It is anticipated to reach USD 43,808.54 MN by 2032, growing at a CAGR of 4.03% during the forecast period.
Glycosaminoglycans Market Size, Share, Growth & Forecast 2032
The glycosaminoglycans (GAGs) market was valued at USD 10,000 million in 2024 and is anticipated to reach USD 19,163.93 million by 2032.
Non-Viral Drug Delivery Systems Market Size, Share and Forecast 2032
The global non-viral drug delivery systems market was valued at USD 15,689 million in 2024 and is projected to reach USD 33,386.1 million by 2032, expanding at a CAGR of 9.9% during the forecast period 2025-2032.
DNA Storage for Data Archiving Market Size, Share and Forecast 2032
The DNA Storage for Data Archiving Market size was estimated at USD 1,180.44 million in 2025 and is expected to reach USD 5,279.86 million by 2032.
mRNA Synthesis And Manufacturing Market Size and Forecast 2032
mRNA Synthesis And Manufacturing Market size was valued USD 1539 million in 2024 and is anticipated to reach USD 1760.73 million by 2032, at a CAGR of 1.7% during the forecast period.
Bioengineered Skin and Skin Substitutes Market Size & Forecast 2032
Bioengineered Skin And Skin Substitutes Market size was valued USD 2183 million in 2024 and is anticipated to reach USD 5845.84 million by 2032.
Nanobiotechnology Market Size, Share, Growth and Forecast 2032
The Nanobiotechnology Market size was valued at USD 40,210 million in 2024 and is anticipated to reach USD 94891.29 million by 2032, at a CAGR of 11.33 % during the forecast period.
Pharmaceutical Rapid Microbiology Testing Market Size and Share 2032
The Pharmaceutical Rapid Microbiology Testing Market size was valued at USD 1,113 million in 2024 and is anticipated to reach USD 3998.75 million by 2032, at a CAGR of 17.34% during the forecast period.
Essential Thrombocythemia Market Size, Share and Forecast 2032
The Essential Thrombocythemia Market size was valued at USD 907.7 million in 2024 and is anticipated to reach USD 1,435.9 million by 2032, at a CAGR of 5.9% during the forecast period.
D Dimer Market Size, Share, Trends, Growth and Forecast 2032
The global D Dimer Market size was estimated at USD 1,320.92 million in 2025 and is expected to reach USD 1,977.90 million by 2032, growing at a CAGR of 6.96% from 2025 to 2032.
Custom Antibody Market Size, Trends, Share and Forecast 2032
The global Custom Antibody Market size was estimated at USD 630.00 million in 2025 and is expected to reach USD 1,091.95 million by 2032, growing at a CAGR of 9.60% from 2025 to 2032.
Culture Media Market Size, Growth, Share and Forecast 2032
The global Culture Media Market size was estimated at USD 4,750.00 million in 2025 and is expected to reach USD 10,176.23 million by 2032, growing at a CAGR of 13.54% from 2025 to 2032.
CRISPR Diagnostics Market Size, Growth, Share and Forecast 2032
The global Crispr Diagnostics Market size was estimated at USD 1,284.57 million in 2025 and is expected to reach USD 2,914.39 million by 2032, growing at a CAGR of 14.63% from 2025 to 2032.
CRISPR and CRISPR Associated Genes Market Size and Forecast 2032
The global Crispr And Crispr Associated Genes Market size was estimated at USD 4,392.16 million in 2025 and is expected to reach USD 9,276.15 million by 2032, growing at a CAGR of 13.27% from 2025 to 2032.
Circulating Tumor Cells Market Size, Growth and Forecast 2032
The global Circulating Tumor Cells Market size was estimated at USD 14,266 million in 2025 and is expected to reach USD 27,800 million by 2032, growing at a CAGR of 10% from 2025 to 2032.
Cell Analysis Instruments Market Size, Share and Forecast 2032
The global Cell analysis instruments market size was estimated at USD 22971 million in 2025 and is expected to reach USD 36454.79 million by 2032, growing at a CAGR of 6.82% from 2025 to 2032.
Cell-Free RNA (cfRNA) Analysis Market Size, Share and Forecast 2032
The global Cell-Free RNA (cfRNA) Analysis Market Size was estimated at USD 42 million in 2025 and is expected to reach USD 109.16 million by 2032, growing at a CAGR of 14.62% from 2025 to 2032.
Cell Therapy CDMO Market Size, Share, Growth and Forecast 2032
The global Cell Therapy CDMO Market size was estimated at USD 5218 million in 2025 and is expected to reach USD 17324.44 million by 2032, growing at a CAGR of 18.7% from 2025 to 2032.
Cell Sorting Market Size, Share, Trend, Growth and Forecast 2032
The global Cell Sorting Market size was estimated at USD 271.25 million in 2025 and is expected to reach USD 480.15 million by 2032, growing at a CAGR of 8.5% from 2025 to 2032.
Cell Reprogramming Market Size, Growth, Share and Forecast 2032
The global Cell Reprogramming Market size was estimated at USD 405.13 million in 2025 and is expected to reach USD 685.37 million by 2032, growing at a CAGR of 7.8% from 2025 to 2032.
Cell Harvesting Market Size, Share, Growth and Forecast 2032
The global Cell Harvesting Market size was estimated at USD 7552 million in 2025 and is expected to reach USD 17493.53 million by 2032, growing at a CAGR of 12.75% from 2025 to 2032.
Laboratory Filtration Market Size, Growth and Forecast 2032
Laboratory Filtration Market size was valued USD 4,500 million in 2024 and is anticipated to reach USD 7,841.49 million by 2032, at a CAGR of 7.19% during the forecast period.
Bioreactors Market Size, Share, Trends, Growth and Forecast 2032
The global Bioreactor Market size was estimated at USD 8845.47 million in 2025 and is expected to reach USD 17457.9 million by 2032, growing at a CAGR of 10.2% from 2025 to 2032.
Built for Decision-Makers
B2B clients served worldwide
Market research reports published
Of Fortune 1,000 companies as clients
Forecast horizon in every report
Frequently Asked Questions
Need a Custom Biotechnology Market Study?
Get a free sample report or speak with a research analyst about your specific segment or region.